课题基金 / 基金详情

Dopamine Transporter--Structure/function Studies Of Tran

Dopamine Transporter--Structure/function Studies Of Tran
多巴胺转运蛋白--Tran的结构/功能研究
批准号:
7320337
负责人:
George Richard Uhl
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

George Richard Uhl的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The dopamine transporter (DAT) has been a principal brain receptor site that has been correlated with the rewarding and euphoric properties of cocaine. MNB scientists cloned the DAT cDNA and gene, and found that deletion of both DAT and SERT are required to eliminate cocaine conditioned place preferences in mice. DAT is required for the actions of each of the current dopamine-selective toxins that produce the best models of Parkinson's disease. Analyses of DAT structure- function relationships, and their relationships with serotonin systems defined through the serotonin receptor subtypes, continued during this year. Work from prior years concerning structure/function relationships of the dopamine tranporter and small molecule substrates and ligands was reported during the year. We also reported further characterization of promoter region haplotypes and their roles in level of expresion variation in vivo. Studies refined the definition of the 5'DAT haplotypes in ways that we reported to correlate with 1)levels of DAT expression in vivo in imaging and 2) levels of DAT expression identified in postmortem human striatal samples. "Triple knockout" mice with alterations of DAT, 5HT1A and 5HT1B receptors produced effects on cocaine reward not identified in single- or double-knockout mice. These insights should continue to help in identification of structure-function relationships relevant to DAT regulation and human individual differences in DAT levels of expression and pharmacology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PTPRD phosphatase inhibitors for stimulant use disorders
  • 批准号:
    10710969
  • 项目类别:
  • 资助金额:
    $38.63万
  • 财政年份:
    2022
  • 负责人:
    George Richard Uhl
  • 依托单位:
PTPRD phosphatase inhibitors for stimulant use disorders
  • 批准号:
    10653070
  • 项目类别:
  • 资助金额:
    $139.15万
  • 财政年份:
    2022
  • 负责人:
    George Richard Uhl
  • 依托单位:
PTPRD phosphatase inhibitors for stimulant use disorders
  • 批准号:
    10457132
  • 项目类别:
  • 资助金额:
    $145.39万
  • 财政年份:
    2022
  • 负责人:
    George Richard Uhl
  • 依托单位:
PTPRD ligands for stimulant and opiate use disorders
国内基金
海外基金
肺炎支原体外排泵ABC Transporter在大环内酯类耐药中的作用机制研究
  • 批准号:
    81672062
  • 项目类别:
    面上项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2016
  • 负责人:
    孙红妹
  • 依托单位:
一个可能与水稻花粉发育相关的ABC transporter 基因的功能验证与分析
  • 批准号:
    30970274
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2009
  • 负责人:
    张毅
  • 依托单位: